07:00 , Oct 3, 2016 |  BC Week In Review  |  Financial News

Noxxon completes private placement

Noxxon Pharma N.V. (Euronext:ALNOX), Berlin, Germany   Business: Cancer   Date completed: 2016-09-23   Type: Private placement   Raised: EUR2.8 million ($3.2 million)   Shares: 132,079   Shares after offering: 2.1 million   Investors: NGN...
02:21 , Jan 8, 2016 |  BC Extra  |  Financial News

Diagnostics plays Guardant, Exosome close private rounds

Two companies in the minimally invasive, fluid-based diagnostics sector announced private funding rounds on Thursday. Guardant Health Inc. (Redwood City, Calif.) said it raised the majority of a planned $100 million series D round. New...
07:00 , Sep 7, 2015 |  BC Week In Review  |  Financial News

Exosome Diagnostics financial update

Exosome Diagnostics Inc. , Cambridge, Mass.   Business: Diagnostic, Cancer   Date announced: 2015-09-02   Note: Exosome raised $17.6 million in an extension of a series B round, bringing the total raised in the round...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Financial News

leon-nanodrugs completes venture financing

leon-nanodrugs GmbH , Munich, Germany   Business: Drug delivery, Supply/Service   Date completed: 2015-07-27   Type: Venture financing   Raised: EUR18.5 million ($20.5 million)   Investors: TVM Capital; Signet Healthcare Partners; LifeCare Partners; CD Ventures;...
08:00 , Dec 8, 2014 |  BC Week In Review  |  Financial News

Curetis financial update

Curetis AG , Holzgerlingen, Germany   Business: Diagnostic   Date announced: 2014-11-24   Note: Curetis raised €14.5 million ($18 million) in an extension of a series B financing, bringing the total raised to €27 million...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Financial News

Exosome Diagnostics completes venture financing

Exosome Diagnostics Inc. , New York, N.Y.   Business: Diagnostic, Cancer   Date completed: 3/11/14   Type: Venture financing   Raised: $27 million   Placement agent: Leerink Partners   Investors: Qiagen N.V. ; Arcus Ventures;...
07:00 , Mar 17, 2014 |  BioCentury  |  Finance

Tuned up for cash flow

Tuned up for cash flow Exosome Diagnostics Inc. will use its $27 million series B round to begin a commercial push of tests created with its minimally invasive, fluid-based molecular diagnostic platform. Partner Qiagen N.V....
00:42 , Mar 12, 2014 |  BC Extra  |  Financial News

Exosome Diagnostics raises $27 million in series B

Exosome Diagnostics Inc. (New York, N.Y.) raised $27 million in the initial close of a series B round co-led by new investors Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN); and Arcus Ventures. New investors Tiger Partners; CD Ventures;...
07:00 , Oct 7, 2013 |  BC Week In Review  |  Financial News

GenomeDx Biosciences completes venture financing

GenomeDx Biosciences Inc. , Vancouver, B.C.   Business: Diagnostic   Date completed: 9/30/13   Type: Venture financing   Raised: Not disclosed   Investors: Merck Global Health Innovation Fund; Baird Venture Partners; Aeris Capital AG; CD...
07:00 , Oct 7, 2013 |  BioCentury  |  Finance

Deciphering GenomeDx

Deciphering GenomeDx While some investors are fleeing the diagnostic space, a series B round for GenomeDx Biosciences Inc. shows there is money out there for companies with a path to reimbursement. The size of the...